Skinvisible, Inc. (SKVI)

Market Cap	1.09M -4.3%
Revenue (ttm)	20.00K
Net Income	-1.03M
EPS	-0.19
Shares Out	5.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	800
Open	0.2010
Previous Close	0.2010
Day's Range	0.2010 - 0.2010
52-Week Range	0.0811 - 0.9000
Beta	1.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Skinvisible

Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its flagship product, Invisicare, is a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. The company also offers non-dermatological formulations for women’s health, pain management, and other markets. In addition, i...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1998
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKVI

Financial Performance

In 2025, Skinvisible's revenue was $20,000, a change of 0.00% compared to the previous year's $20,000. Losses were -$1.06 million, 88.1% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error